Potent Anti-Myeloma Activity of the TOPK inhibitor OTS514 in Pre-Clinical Models
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
Evaluation of gene expression upon treatment with OTS514 in combination with existing thereapeutics in H929 cells H929 cells treated for 24h with DMSO control or OTS514 (15 nM) and/or carfilzomib(CFZ, 5nM) and/or lenalidomide (LEN, 15µM)
创建时间：
2019-11-13
